INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,108,859 | +18.4% | 4,241,935 | -1.0% | 0.36% | +22.8% |
Q2 2023 | $90,432,891 | +43.1% | 4,285,919 | +15.6% | 0.29% | +31.8% |
Q1 2023 | $63,198,860 | -6.7% | 3,706,678 | +9.3% | 0.22% | -15.1% |
Q4 2022 | $67,735,497 | -11.6% | 3,390,165 | -4.7% | 0.26% | -14.5% |
Q3 2022 | $76,609,000 | +10.1% | 3,556,584 | +0.8% | 0.30% | +17.4% |
Q2 2022 | $69,554,000 | -17.7% | 3,527,089 | -1.9% | 0.26% | +2.4% |
Q1 2022 | $84,497,000 | -36.9% | 3,595,626 | -26.8% | 0.25% | -30.4% |
Q4 2021 | $133,861,000 | -2.3% | 4,914,140 | -1.2% | 0.36% | -6.2% |
Q3 2021 | $137,040,000 | -4.2% | 4,976,041 | -1.0% | 0.39% | -14.0% |
Q2 2021 | $143,045,000 | +11.6% | 5,026,184 | +33.5% | 0.45% | +8.2% |
Q1 2021 | $128,210,000 | +4.0% | 3,764,236 | +1.6% | 0.42% | +1.2% |
Q4 2020 | $123,294,000 | +60.7% | 3,703,626 | +55.2% | 0.41% | +37.1% |
Q3 2020 | $76,718,000 | +240.0% | 2,386,996 | +191.3% | 0.30% | +225.0% |
Q2 2020 | $22,566,000 | +96.7% | 819,391 | +14.5% | 0.09% | +64.3% |
Q1 2020 | $11,471,000 | – | 715,568 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |